Guardian Pharmacy Services (NYSE:GRDN) Price Target Raised to $51.00 at Truist Financial

Guardian Pharmacy Services (NYSE:GRDN) had its price objective raised by Truist Financial from $47.00 to $51.00 in a report published on Monday morning, Marketbeat Ratings reports. Truist Financial currently has a buy rating on the stock.

A number of other research analysts have also recently issued reports on the stock. Weiss Ratings raised shares of Guardian Pharmacy Services from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, August 20th. Oppenheimer boosted their price objective on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a report on Friday, August 7th. Wall Street Zen downgraded Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a research report on Saturday. Finally, Bank of America raised their target price on Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a “buy” rating in a research note on Wednesday, June 17th. Eight investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $44.50.

Guardian Pharmacy Services Stock Down 1.8%

GRDN opened at $44.18 on Monday. Guardian Pharmacy Services has a 52-week low of $23.14 and a 52-week high of $48.33. The company has a market cap of $2.20 billion, a P/E ratio of 42.89, a price-to-earnings-growth ratio of 2.33 and a beta of 0.06. The firm’s 50-day moving average price is $40.56 and its 200-day moving average price is $38.99.

Guardian Pharmacy Services (NYSE:GRDN) last released its earnings results on Thursday, August 6th. The company reported $0.29 EPS for the quarter, topping analysts’ consensus estimates of $0.26 by $0.03. The company had revenue of $351.77 million during the quarter, compared to analysts’ expectations of $340.45 million. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. On average, research analysts anticipate that Guardian Pharmacy Services will post 1.19 EPS for the current fiscal year.

Hedge Funds Weigh In On Guardian Pharmacy Services

Institutional investors have recently bought and sold shares of the business. Jennison Associates LLC boosted its holdings in shares of Guardian Pharmacy Services by 609.5% in the 1st quarter. Jennison Associates LLC now owns 822,784 shares of the company’s stock valued at $30,986,000 after acquiring an additional 706,823 shares during the last quarter. Braun Stacey Associates Inc. purchased a new position in shares of Guardian Pharmacy Services during the second quarter worth $14,234,000. Sei Investments Co. raised its holdings in shares of Guardian Pharmacy Services by 40.5% during the first quarter. Sei Investments Co. now owns 358,181 shares of the company’s stock worth $13,489,000 after purchasing an additional 103,177 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in Guardian Pharmacy Services by 200.0% during the first quarter. Dimensional Fund Advisors LP now owns 208,594 shares of the company’s stock valued at $7,855,000 after purchasing an additional 139,070 shares during the period. Finally, Ranger Investment Management L.P. acquired a new position in Guardian Pharmacy Services during the second quarter valued at $7,263,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc is a long-term care pharmacy company that provides prescription medications and related pharmacy services to residents of assisted living communities, skilled nursing facilities, memory care centers and other institutional care settings.

The company’s services include medication dispensing and packaging, prescription delivery, medication management, pharmacy consulting and clinical support. Guardian works with care providers, residents and their families to help coordinate medication regimens, improve adherence and support the ongoing pharmacy needs of patients who may require complex or recurring treatments.

Guardian Pharmacy Services operates through a network of community-based pharmacies serving long-term care customers in multiple U.S.